AI Signal & Stock Analysis · Strong ↑
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for JNJ is Strong ↑; the stock is at $261.22 (-0.33% today); neutral (RSI 56); technical trend is down-trend; news sentiment is nan.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Strong ↑ |
|---|---|
| Price | $261.22 |
| Change today | -0.33% |
| RSI (14) | 56.28 |
| Relative volume | 0.28 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $629.5B |
| Forward P/E | 20.49 |
| 52-week high | -5.0% away |
| 52-week low | +51.1% above |
| Technical trend | Down-trend (since 2026-05-26) |
| News sentiment | Nan |
| Sector | Healthcare-Pharma |
| Next earnings | 7/15/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns JNJ (Johnson & Johnson) a Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
JNJ's RSI is neutral (RSI 56). A reading above 70 is typically considered overbought and below 30 oversold.
JNJ is trading about 5% below its 52-week high and 51% above its 52-week low as of Aug 14 2026, 1:04 PM.
JNJ's next earnings date is 7/15/2026 8:30:00 AM.
JNJ is classified under Healthcare-Pharma in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.